Literature DB >> 18060952

Sexual function following anal sphincteroplasty for fecal incontinence.

Rachel N Pauls1, W Andre Silva, Christopher M Rooney, Sam Siddighi, Steven D Kleeman, Vicki Dryfhout, Mickey M Karram.   

Abstract

OBJECTIVE: The objective of the study was to assess sexual function following anal sphincteroplasty and determine associations between sexual function and fecal incontinence. STUDY
DESIGN: Women 1 year or longer following anal sphincteroplasty with or without other reconstructive surgery were matched to controls. Subjects were mailed the Female Sexual Function Index (FSFI), Fecal Incontinence Quality of Life (FIQOL), Fecal Incontinence Severity Index (FISI), and a general questionnaire.
RESULTS: Twenty-six cases and 26 controls responded; 73% were sexually active. Sexual function scores were similar between the groups. Seventeen sphincteroplasty patients and 8 controls complained of fecal incontinence at follow up. Significant correlations were found between FSFI domains and the FIQOL depression/self-perception scale, FISI fecal incontinence of solid stool, and total FISI.
CONCLUSION: Sexual activity and function was similar following anal sphincteroplasty, compared with controls, despite worse symptoms of fecal incontinence. Fecal incontinence of solid stool and depression related to fecal incontinence were correlated with poorer sexual function.

Entities:  

Mesh:

Year:  2007        PMID: 18060952     DOI: 10.1016/j.ajog.2007.08.011

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  9 in total

1.  Sexual function in women with anal incontinence using a new instrument: the PISQ-IR.

Authors:  Rachel N Pauls; Rebecca G Rogers; Mitesh Parekh; Joan Pitkin; Dorothy Kammerer-Doak; Peter Sand
Journal:  Int Urogynecol J       Date:  2014-11-13       Impact factor: 2.894

2.  Anal Intercourse and Fecal Incontinence: Evidence from the 2009-2010 National Health and Nutrition Examination Survey.

Authors:  Alayne D Markland; Gena C Dunivan; Camille P Vaughan; Rebecca G Rogers
Journal:  Am J Gastroenterol       Date:  2016-01-12       Impact factor: 10.864

Review 3.  Sexual satisfaction in the elderly female population: A special focus on women with gynecologic pathology.

Authors:  Elena S Ratner; Elisabeth A Erekson; Mary Jane Minkin; Kelly A Foran-Tuller
Journal:  Maturitas       Date:  2011-09-22       Impact factor: 4.342

4.  The association between fecal incontinence and sexual activity and function in women attending a tertiary referral center.

Authors:  Sara B Cichowski; Yuko M Komesu; Gena C Dunivan; Rebecca G Rogers
Journal:  Int Urogynecol J       Date:  2013-02-07       Impact factor: 2.894

Review 5.  Shortcomings/strengths of specific sexual function questionnaires currently used in urogynecology: a literature review.

Authors:  Tola B Omotosho; Rebecca G Rogers
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2009-05

6.  Fecal incontinence decreases sexual quality of life, but does not prevent sexual activity in women.

Authors:  Laurel R Imhoff; Jeanette S Brown; Jennifer M Creasman; Leslee L Subak; Stephen K Van den Eeden; David H Thom; Madhulika G Varma; Alison J Huang
Journal:  Dis Colon Rectum       Date:  2012-10       Impact factor: 4.585

7.  Fecal incontinence, sexual complaints, and anorectal function after third-degree obstetric anal sphincter injury (OASI): 5-year follow-up.

Authors:  A P Visscher; T J Lam; N Hart; R J F Felt-Bersma
Journal:  Int Urogynecol J       Date:  2013-11-07       Impact factor: 2.894

8.  Women's experiences following severe perineal trauma: a qualitative study.

Authors:  Holly Priddis; Virginia Schmied; Hannah Dahlen
Journal:  BMC Womens Health       Date:  2014-02-21       Impact factor: 2.809

9.  Randomized, Double-Blind, Placebo-Controlled Trial on the Efficacy of Hyaluronidase in Preventing Perineal Trauma in Nulliparous Women.

Authors:  Hayan Kwon; Hyun Soo Park; Jae Yoon Shim; Kyo Won Lee; Suk Joo Choi; Gyu Yeon Choi
Journal:  Yonsei Med J       Date:  2020-01       Impact factor: 2.759

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.